MSF warns governments are failing to test, treat and prevent TB in children

MSF responds to WHO’s annual global TB report: implores governments to use recent TB wins to beat back deadly infectious disease

Equitable access to lifesaving medical products must be prioritised by avoiding country hoarding and removing intellectual property barriers for people everywhere 

In step to expand people's access to HIV treatment, Colombia plans to overcome patent barriers and issue a compulsory license

MSF responds to groundbreaking news that Johnson & Johnson will not enforce patents on key TB drug bedaquiline in low- and middle-income countries

Commitments made in today's UN TB Declaration to scale up TB testing and treatment, and improve TB care for children, require immediate, concrete action

TB test price reduction by Cepheid and Danaher is an important step in the right direction

Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need